Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | KCNN4 | O15554 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | KIF11 | P52732 | 8/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2969422 | 0.79 | MAPT (0.48) | CYP2D6CYP1A2KMT2AMAPTCES1 | |
| SCHEMBL6554389 | 0.76 | MAPK1 (0.38) | CYP2D6CYP1A2CES1KCNN4TSHR | |
| SCHEMBL10800116 | 0.74 | CES1 (0.42) | CYP2D6CYP1A2CES1KCNN4LMNA | |
| SCHEMBL490866 | 0.73 | CES1 (0.47) | CYP2D6CYP1A2KMT2AMAPTCES1 | |
| SCHEMBL8035867 | 0.71 | CES1 (0.46) | KMT2AMAPTCES1KCNN4LMNA | |
| SCHEMBL7691954 | 0.71 | CES1 (0.44) | CYP2D6CYP1A2KMT2AMAPTCES1 | |
| SCHEMBL10884190 | 0.70 | KCNN4 (0.44) | CYP2D6CYP1A2KMT2AMAPTCES1 | |
| SCHEMBL27315793 | 0.69 | ATM (0.44) | CYP2D6CYP1A2KMT2AMAPTCES1 | |
| SCHEMBL16713397 | 0.69 | CYP2D6 (0.49) | CYP2D6CYP1A2KMT2AMAPTCES1 | |
| SCHEMBL9049025 | 0.69 | TRPA1 (0.51) | CYP1A2KMT2ALMNATSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12152279-B2 | Photoactive compounds and methods for biomolecule detection and sequencing | VIBRANT HOLDINGS, LLC (US) | 2024-11-26 | — | — | US | claimed |
| US-20220162698-A1 | PHOTOACTIVE COMPOUNDS AND METHODS FOR BIOMOLECULE DETECTION AND SEQUENCING | VIBRANT HOLDINGS, LLC | 2022-05-26 | — | — | US | claimed |
| US-11168365-B2 | Photoactive compounds and methods for biomolecule detection and sequencing | VIBRANT HOLDINGS, LLC (US) | 2021-11-09 | — | — | US | claimed |
| WO-2018218250-A2 | PHOTOACTIVE COMPOUNDS AND METHODS FOR BIOMOLECULE DETECTION AND SEQUENCING | VIBRANT HOLDINGS, LLC (US) | 2018-11-29 | — | — | WO | claimed |
| EP-2003501-B1 | Inkless reimageable printing paper and method | XEROX CORP (US) | 2010-10-27 | — | — | EP | claimed |
| US-7582398-B2 | Inkless reimageable printing paper and method | XEROX CORPORATION (US) | 2009-09-01 | — | — | US | claimed |
| US-7572569-B2 | Inkless printing paper and method | XEROX CORPORATION (US) | 2009-08-11 | — | — | US | claimed |
| US-7553603-B2 | Inkless printing paper and method | XEROX CORPORATION (US) | 2009-06-30 | — | — | US | claimed |
| US-20080311518-A1 | INKLESS PRINTING PAPER AND METHOD | XEROX CORPORATION (US) | 2008-12-18 | — | — | US | claimed |
| US-20080311516-A1 | INKLESS PRINTING PAPER AND METHOD | XEROX CORPORATION (US) | 2008-12-18 | — | — | US | claimed |
| US-20080311492-A1 | INKLESS REIMAGEABLE PRINTING PAPER AND METHOD | XEROX CORPORATION (US) | 2008-12-18 | — | — | US | claimed |
| EP-2003502-A1 | Inkless printing paper and method | Xerox Corporation (US) | 2008-12-17 | — | — | EP | claimed |
| EP-2003503-A1 | Inkless printing paper and method | Xerox Corporation (US) | 2008-12-17 | — | — | EP | claimed |
| EP-2003501-A1 | Inkless reimageable printing paper and method | Xerox Corporation (US) | 2008-12-17 | — | — | EP | claimed |
| US-20260125496-A1 | MONOMERS AND CURABLE COMPOSITIONS FOR CRYSTALLINITY CONTROL IN POLYMERIC MATERIALS FOR 3D-PRINTED DENTAL DEVICES | ALIGN TECHNOLOGY INC (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4704757-A1 | SEMICRYSTALLINE SULFUR CONTAINING POLYMERS FOR ORTHODONTIC APPLICATIONS | Align Technology, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4685194-A1 | DEGRADABLE CROSSLINKING AGENT | NAGASE CHEMTEX CORPORATION (JP) | 2026-01-28 | — | — | EP | disclosed |
| EP-1795553-A1 | PROCESS FOR PRODUCING FOAM | Oji Paper Co., Ltd. (JP) | 2007-06-13 | — | — | EP | disclosed |
| US-20060210785-A1 | Foamed product in a sheet form and method for production thereof | OJI PAPER CO., LTD. (JP) | 2006-09-21 | — | — | US | disclosed |
| EP-1647570-A1 | FOAMED PRODUCT IN A SHEET FORM AND METHOD FOR PRODUCTION THEREOF | Oji Paper Co., Ltd. (JP) | 2006-04-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125496-A1 | MONOMERS AND CURABLE COMPOSITIONS FOR CRYSTALLINITY CONTROL IN POLYMERIC MATERIALS FOR 3D-PRINTED DENTAL DEVICES | SMCHD1, SMC4, SMC3 | CYP2D6 2008/4885CYP1A2 1547/4885KMT2A 456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.